Press release
Pain Therapeutics - Keynote Opening Addresses From The Pain Society And Eptiva Therapeutics
P-375 PR2
Industry leaders will uncover the latest advancements in the field, highlighting the use of opioids and the future for cannabinoids within the pain therapeutics field.
Take advantage of the early bird offer and register by 28th February to save £200, to secure your attendance please visit: www.pain-therapeutics.co.uk/PR2openpr
This year's conference day one and two opening keynotes will focus first to look deeper into understanding chronic pain and secondly to delve into developing analgesic for treatment of pain including case studies.
SMi Group are delighted to have The British Pain Society and Eptiva Therapeutics Ltd join the conference, both of whom will be delivering keynote opening address on:
"Pain is Pain - or is it?" - Perspectives on Chronic Pain
•Chronic pain results in major health and welfare expenditure, but its management is not well supported
•The multifactorial biopsychosocial aspects of pain is often not acknowledged resulting in poor management
•Pharmacological management are often targeting symptom control rather than treating the cause
•Multimodal interdisciplinary management is needed but is delivered piece-meal
Arun Bhaskar, President, The British Pain Society
Personalized Analgesics® research: a novel network biology approach to transform pain R&D
•Chronic pain is a huge burden to patients and society as a whole with a lack of safe and effective analgesic treatments
•Innovation in the pain area is extremely low with few new medicines reaching patients due to exceptionally high attrition rates in R&D.
•New transformative approaches for pain drug development are required to improve the probability of R&D success and encourage increased investments into the area
•This presentation will describe a novel Personalized Analgesics® network biology approach to link research targets to disease, based on our development of the Pain Landscape® the Pain diseasome®
•Creating R&D methods that link the mechanistic research target to the most appropriate disease can develop more precision-analgesics de-risking R&D and helping create improved solutions for patients
Mark Field, CEO and Co-founder, Eptiva Therapeutics Ltd.
The Pain Therapeutics Conference will aim to discuss new case studies and regulatory perspectives will bring together the challenges and successes of both pre-clinical and clinical development to equip attendees with the necessary knowledge to advance the pain therapeutic industry.
To find out more about the two-day agenda and speaker line-up, please visit: www.pain-therapeutics.co.uk/PR2openpr
Proudly sponsored by: CDHR
For sponsorship enquiries contact Andrew Gibbons on +44 (0)20 7827 6156 or agibbons@smi-online.co.uk
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk
SMi's 22nd Annual Pain Therapeutics Conference
Conference: 4th - 5th May 2022
London, UK
www.pain-therapeutics.co.uk/PR2openpr
#SMiPain
--- ENDS -
India House, 45 Curlew Street
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pain Therapeutics - Keynote Opening Addresses From The Pain Society And Eptiva Therapeutics here
News-ID: 2554927 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for Pain
Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,…
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big…
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy.
Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have…
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Global Post-operative Pain Management Market - Overview
Post-operative pain management is the most important part…
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in…
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and…
